Non-small cell lung squamous cell carcinoma tissue microarray (2015 WHO Classification), 2 cores per case. Pathology grade, TNM Classification and Clinical Stages information available. Replacing LC242.
- 10 cases of lung squamous cell carcinoma(3 cases keratinizing squamous cell carcinoma and 7 non-keratinizing squamous cell carcinoma)
- 1 case of normal lung tissue and adjacent normal lung tissue
Price
$55.00
Catalogue No | RLN242a |
Species | Human |
Fixative | Formalin |
Total Cases | 12 |
Total Cores | 24 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | |||||||||||||||||||||||||||||||||||||||||||||||||||||
B | LU | LU | LU | LU | LU | LU | |||||||||||||||||||||||||||||||||||||||||||||||||||||
C | LU | LU | LU | LU | LU | LU | |||||||||||||||||||||||||||||||||||||||||||||||||||||
D | LU | LU | LU | LU | LU | LU | |||||||||||||||||||||||||||||||||||||||||||||||||||||
N | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 58 | M | Lung | Keratinizing squamous cell carcinoma | 1 | T3N1M0 | IIIA | Malignant |
2 | A2 | 58 | M | Lung | Keratinizing squamous cell carcinoma | 1 | T3N1M0 | IIIA | Malignant |
3 | A3 | 72 | M | Lung | Non-keratinizing squamous cell carcinoma | 1 | T3N2M0 | IIIA | Malignant |
4 | A4 | 72 | M | Lung | Non-keratinizing squamous cell carcinoma | 1 | T3N2M0 | IIIA | Malignant |
5 | A5 | 50 | M | Lung | Non-keratinizing squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
6 | A6 | 50 | M | Lung | Non-keratinizing squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
7 | B1 | 63 | M | Lung | Keratinizing squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
8 | B2 | 63 | M | Lung | Keratinizing squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
9 | B3 | 67 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
10 | B4 | 67 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
11 | B5 | 62 | M | Lung | Non-keratinizing squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
12 | B6 | 62 | M | Lung | Non-keratinizing squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
13 | C1 | 61 | M | Lung | Non-keratinizing squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
14 | C2 | 61 | M | Lung | Non-keratinizing squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
15 | C3 | 71 | F | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
16 | C4 | 71 | F | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
17 | C5 | 77 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N1M0 | IIB | Malignant |
18 | C6 | 77 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N1M0 | IIB | Malignant |
19 | D1 | 45 | F | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
20 | D2 | 45 | F | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
21 | D3 | 54 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
22 | D4 | 54 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
23 | D5 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
24 | D6 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |